Plus   Neg

CytomX Therapeutics Inc. (CTMX) Has Jumped To A New High On Amgen News

CytomX Therapeutics Inc. (CTMX) announced after the bell Tuesday that it has entered into a strategic collaboration with Amgen (AMGN) in immuno-oncology.

CytomX Therapeutics has gapped open sharply higher Wednesday morning and is now up 3.44 at $22.44 on above average volume. The stock has leaped to a new high for the year.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Follow RTT